Search research articles
Contact Us
Filters
Showing results (11-20 of 23) with videos related to
Page
of 3
Sort By:
Plos One
|
January 5, 2012
Genome-wide identification of transcriptional start sites in the plant pathogen Pseudomonas syringae pv. tomato str. DC3000
Melanie J Filiatrault, Paul V Stodghill, Christopher R Myers, et al.
Bioconjugate Chemistry
|
May 22, 2016
Determination of Antibody-Drug Conjugate Released Payload Species Using Directed in Vitro Assays and Mass Spectrometric Interrogation
Andrew J Bessire, T Eric Ballard, Manoj Charati, et al.
Msphere
|
February 21, 2017
Piericidin A1 Blocks <i>Yersinia</i> Ysc Type III Secretion System Needle Assembly
Jessica M Morgan, Miles C Duncan, Kevin S Johnson, et al.
The Journal of Biological Chemistry
|
June 3, 2004
Niemann-Pick C1 Like 1 (NPC1L1) is the intestinal phytosterol and cholesterol transporter and a key modulator of whole-body cholesterol homeostasis
Harry R Davis, Li-Ji Zhu, Lizbeth M Hoos, et al.
Journal of Lipid Research
|
November 9, 2006
Fluorogenic substrates for high-throughput measurements of endothelial lipase activity
Lyndon J Mitnaul, Jenny Tian, Charlotte Burton, et al.
The Journal of Biological Chemistry
|
January 16, 2002
A potent synthetic LXR agonist is more effective than cholesterol loading at inducing ABCA1 mRNA and stimulating cholesterol efflux
Carl P Sparrow, Joanne Baffic, My-Hanh Lam, et al.
Endocrinology
|
June 20, 2002
A novel liver X receptor agonist establishes species differences in the regulation of cholesterol 7alpha-hydroxylase (CYP7a)
John G Menke, Karen L Macnaul, Nancy S Hayes, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 25, 2005
Discovery and development of dimeric podocarpic acid leads as potent agonists of liver X receptor with HDL cholesterol raising activity in mice and hamsters
Sheo B Singh, John G Ondeyka, Weiguo Liu, et al.
Journal of Medicinal Chemistry
|
November 29, 2014
Discovery of cytotoxic dolastatin 10 analogues with N-terminal modifications
Andreas Maderna, Matthew Doroski, Chakrapani Subramanyam, et al.
Molecular Cancer Therapeutics
|
July 6, 2022
Anti-Extra Domain B Splice Variant of Fibronectin Antibody-Drug Conjugate Eliminates Tumors with Enhanced Efficacy When Combined with Checkpoint Blockade
Andrea T Hooper, Kimberly Marquette, Chao-Pei Betty Chang, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 23) with videos related to
Sort By:
Page
of 3
Plos One
|
January 5, 2012
Genome-wide identification of transcriptional start sites in the plant pathogen Pseudomonas syringae pv. tomato str. DC3000
Melanie J Filiatrault, Paul V Stodghill, Christopher R Myers, et al.
Bioconjugate Chemistry
|
May 22, 2016
Determination of Antibody-Drug Conjugate Released Payload Species Using Directed in Vitro Assays and Mass Spectrometric Interrogation
Andrew J Bessire, T Eric Ballard, Manoj Charati, et al.
Msphere
|
February 21, 2017
Piericidin A1 Blocks <i>Yersinia</i> Ysc Type III Secretion System Needle Assembly
Jessica M Morgan, Miles C Duncan, Kevin S Johnson, et al.
The Journal of Biological Chemistry
|
June 3, 2004
Niemann-Pick C1 Like 1 (NPC1L1) is the intestinal phytosterol and cholesterol transporter and a key modulator of whole-body cholesterol homeostasis
Harry R Davis, Li-Ji Zhu, Lizbeth M Hoos, et al.
Journal of Lipid Research
|
November 9, 2006
Fluorogenic substrates for high-throughput measurements of endothelial lipase activity
Lyndon J Mitnaul, Jenny Tian, Charlotte Burton, et al.
The Journal of Biological Chemistry
|
January 16, 2002
A potent synthetic LXR agonist is more effective than cholesterol loading at inducing ABCA1 mRNA and stimulating cholesterol efflux
Carl P Sparrow, Joanne Baffic, My-Hanh Lam, et al.
Endocrinology
|
June 20, 2002
A novel liver X receptor agonist establishes species differences in the regulation of cholesterol 7alpha-hydroxylase (CYP7a)
John G Menke, Karen L Macnaul, Nancy S Hayes, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 25, 2005
Discovery and development of dimeric podocarpic acid leads as potent agonists of liver X receptor with HDL cholesterol raising activity in mice and hamsters
Sheo B Singh, John G Ondeyka, Weiguo Liu, et al.
Journal of Medicinal Chemistry
|
November 29, 2014
Discovery of cytotoxic dolastatin 10 analogues with N-terminal modifications
Andreas Maderna, Matthew Doroski, Chakrapani Subramanyam, et al.
Molecular Cancer Therapeutics
|
July 6, 2022
Anti-Extra Domain B Splice Variant of Fibronectin Antibody-Drug Conjugate Eliminates Tumors with Enhanced Efficacy When Combined with Checkpoint Blockade
Andrea T Hooper, Kimberly Marquette, Chao-Pei Betty Chang, et al.
Page
of 3